MULTIPLE SCLEROSIS, RELAPSING-REMITTING

This study compares two daily pills, ozanimod and fingolimod, in children and teens aged 10-17 with relapsing-remitting multiple sclerosis (RRMS). The goal is to see which drug better prevents relapses and reduces brain lesions. Participants will be randomly assigned to one of th…

This study tests whether clemastine fumarate, an allergy medicine, can help repair the protective coating (myelin) around nerve cells in people with multiple sclerosis (MS). About 74 adults with relapsing-remitting MS will receive either the drug or a placebo, and advanced MRI sc…

This study tests if a non-invasive brain stimulation technique called repetitive Transcranial Magnetic Stimulation (rTMS) can reduce fatigue in people with multiple sclerosis (MS). Sixty participants with MS and moderate-to-severe fatigue will receive either real or sham (fake) r…

This study tests a wearable device called the Cionic Neural Sleeve in 14 people with multiple sclerosis (MS). The sleeve uses electrical signals to help improve walking speed, reduce disability, and lower fall risk. Participants wear the sleeve for up to 8 hours a day while resea…

This study tests whether a breathing method called acute intermittent hypoxia (AIH) can improve arm and hand function in people with multiple sclerosis. AIH involves breathing short bursts of low oxygen, which may help the brain and spinal cord form new connections. Researchers w…

This study looks at whether people with multiple sclerosis (MS) can learn new skills to avoid falling after being exposed to slips and trips. Researchers will have 64 participants with relapsing-remitting MS walk on a treadmill or overground while being gently pulled off balance.…

This study tests a breathing technique called Acute Intermittent Hypoxia (AIH) in people with multiple sclerosis. Participants breathe short bursts of low oxygen (like at high altitude) to see if it can improve ankle strength and change brain activity. The goal is to understand h…

This study is collecting health data from 100 people with multiple sclerosis (MS) to find new ways to track the disease using artificial intelligence. Researchers will look at medical images, blood tests, and smartphone data to better understand how MS changes over time. The goal…